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ABSTRACT 
Background 
Independent ethics review is one of the fundamental principles of research ethics. The body of literature 
has documented increasing bureaucratic delays associated with ethics review, which has impacted the 
start of research activities. This study aimed to determine the extent of variability in turnaround times 
for protocol review among different institutional review boards (IRBs) within Tanzania. It also assessed 
the challenges and experiences of submitting and reviewing protocols after introducing the tablet PC, 
from the perspectives of Ifakara Health Institute IRB (IHI-IRB) members and investigators.  
 
Methods 
This cross-sectional study employed a mixed-methods approach which consisted of qualitative and 
quantitative approaches. The quantitative data were obtained retrospectively from databases of seven 
selected IRBs in Tanzania. Purposive sampling was used to select seven IRBs for inclusion in the study. 
Seven IRB secretaries and their assistants from five institutions were interviewed to respond to the 
research questions. In addition, 19 in-depth interviews were conducted with IRB members and 
investigators to explore their experiences of using tablet PCs in reviewing protocols and in submitting 
electronic proposals, respectively. This study was conducted in mainland Tanzania and Zanzibar. 
Quantitative secondary data were analysed using Stata software (quantitative data analysis software, 
version 10). Qualitative data were categorised in an Excel spreadsheet and analysed using thematic 
analysis.  
 
Results 
The median time for ethics review across the visited sites was 32 days and ranged from 1 to 396 days. 
Qualitative results found that eleven thematic issues emerged from in-depth interviews with IRB 
members and the secretariat in the visited study areas. Generally, looking into the procedures for 
submission of protocols to the secretariat of the IRB, these were more or less the same across IRB 
institutions in Tanzania. However, investigators sometimes failed to adhere to the submission checklist 
and guidelines which resulted in delays in the timeous review of protocols. Most of the IRB members 
and investigators preferred electronic submission for its ease of use and reduced burdens associated 
with paper-based submissions, such as printing, distribution and misplacing of protocols.  
 
Conclusion  
Data from this study suggest that there is an urgent need to address the issues raised in order to improve 
the turnaround time of protocol review in Tanzania. Investigators should adhere to the submission 
checklist and guidelines to avoid delays in the ethics approval process. Ethics review boards need to 
invest in technology and system strengthening to facilitate timeous processing of ethics applications.  
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
 
1.1 History of research abuses 
Independent ethics review is one of the fundamental principles of research ethics. Ethics review of a 
research proposal involving human participants is a procedure that starts with the submission of a 
proposal to the institutional review board (IRB), research ethics committee (REC), or ethics review 
board (ERB) (as referred to in some countries) for critical review of the proposal, data collection tools, 
informed consent documents, data-sharing plan, investigator CVs, and any other relevant documents 
related to the study (Kruger, Ndebele & Horn, 2014; Page & Nyeboer, 2017).  
 
The aim of research ethics is to minimise the possibility of exploitation and research fatigue by ensuring 
that research participants are not merely used but are treated with full respect and dignity while 
contributing to the improvement of society or knowledge. Ethics review of research proposals became 
established after a long history of unethical research that happened during the Second World War, as 
well as the Tuskegee Syphilis Study conducted in the United States (US) (Thomas & Quinn, 1991). In 
the Tuskegee study, researchers did not inform participants adequately about the study, and even when 
treatment became available, participants were denied the right to get medication; this led to the general 
mistrust of public health research still apparent today (Thomas & Quinn, 1991; Wassenaar, 2006). 
Ethics violations in research still persist. For example, as recently as 2014, Facebook employees 
performed an experiment titled “Massive-scale contagion via social networks” without their research 
participants’ knowledge or consent (Kramer, Guillory & Hancock, 2014).  
 
1.1.1 Obligation to obtain ethical approval 
According to the World Medical Association (2013), the declaration of Helsinki (1964) stipulated two 
major requirements prior to the implementation of clinical trial. Firstly all research participants must 
understand the risk, benefits and alternatives of the experiment so that they can participate voluntarily, 
that is, provide informed consent. This requirement mandates the importance of the investigator 
ensuring that potential participants have understood the research (WMA, 2013). Secondly, the 
declaration stipulated that there should be a committee disconnected from the research to independently 
review the proposed research prior to implementation. This committee should be located in the country 
where the research will be conducted. The ethics committee should be independent and transparent in 
its functioning, and must be comprised of qualified people. Likewise, ethical committees have the 
authority to approve or reject research protocols depending of the scientific and ethical merit of the 
research (Silaigwana & Wassenaar, 2019). The committee is expected to monitor ongoing research, 
 2 
taking into account laws and regulations of the country where the research is implemented (WMA, 
2013).  
 
1.2 Prominent guidance documents 
The Nuremburg Code was published in response to the abuses of the Nazi research during the Second 
World War and marked an important foundation of contemporary medical ethics in the contexts of both 
research and treatment (Arras, 1991). The trial of several Nazi doctors in Nuremberg was followed by 
the publication of the Nuremberg Code in 1948 (Amdur & Bankert, 2010). The Nuremberg Code’s 
ethical guidelines reaffirmed the legitimacy of clinical experiments, while providing certain safeguards 
for research participants (Faden, Lederer & Moreno, 1996). This code emphasised the importance of 
individual informed consent in all research with human participants, so as to prevent a recurrence of 
abuses by scientists in the name of research (Leach, Stevens, Lindsay, Ferrero & Korkut, 2012).  
 
The Nuremberg Code is relatively restrictive concerning persons competent of consenting to research, 
and thus the World Medical Association published the more detailed Declaration of Helsinki in 1964 
(Williams, 2008). The Helsinki Declaration, among other statements, stipulated the health priority of 
the trial participants (World Medical Association (WMA), 2013). The Helsinki Declaration states that:  
It is the duty of physicians who are involved in medical research to protect the life, health, 
dignity, integrity, right to self-determination, privacy, and confidentiality of personal 
information of research participants. The responsibility for the protection of research 
participants must always rest with the physician or other health care professionals and never 
with the research participants, even though they have given consent. (WMA, 2013, p. 2191)  
 
Likewise, the Helsinki Declaration underscored that research with patients or healthy volunteers should 
be conducted with the supervision of qualified researchers (WMA, 2013). In addition, the Helsinki 
Declaration stated that research protocols should be submitted for ethics review and approved by IRBs 
before the study begins. These committees should be transparent in their functioning and must be 
independent of the researcher, the sponsor and any other undue influence (WMA, 2013). The main 
obligation of IRBs is to protect potential research participants, but they must also take into account 
potential risks and benefits for the community in which the research will be implemented. The ultimate 
goal of ethics review is to promote high ethical standards in research (World Health Organization 
(WHO), 2009). 
 
The ethics committee should also follow the laws and regulations of the particular country or countries 
in which the research is to be performed. In addition, the committee must follow international norms 
and standards, where applicable (WMA, 2013). Review is also essential if the researchers plan to 
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publish the results of their study, as most medical journals do not publish the findings of research that 
has not received ethics approval (WHO, 2009). 
 
Over time, the authors of the Helsinki Declaration were concerned that the Nuremberg Code did not 
provide adequate guidance for many research activities carried out by medical doctors with human 
participants and therefore added provisions for authorisation by proxy consent for the participation of 
children in research (Levine, 1996). As with other guidelines, the Helsinki Declaration has several 
editions and is updated periodically. 
 
The regulations for the protection of human subjects developed by the Department of Health and Human 
Services (DHHS), published in 1974, also included a requirement for ethics review (Grady, 2015). 
Therefore, the term ‘institutional review board’ was introduced at that time. Hence, the World Medical 
Association also introduced review by an independent committee for oversight of science and ethics 
into the 1975 revision of the Declaration of Helsinki (Riis, 1977). These regulations were published in 
response to violations in research, especially during the second world war. For example, the NAZI 
regime was widely known in the US by 1946. So, these regulations are relevant as they aimed at 
protecting participants from harm. Local regulations are being informed by the international regulation 
to protect human subjects (Mashalla et al., 2019). 
 
Another important guiding document in research ethics is the Belmont Report of 1979, which provided 
a framework to guide the resolution of ethical problems in research with human participants (Amdur & 
Bankert, 2010). This report identified three fundamental ethical principles, namely, respect for persons, 
beneficence, and justice (Cassell, 2000). Hence, this provided a basis for the conduct of ethical research 
involving human participants (Beauchamp, 2003; Cassell, 2000). The report also highlighted three 
important principles, namely, informed consent and protecting vulnerable groups, risk-benefit 
considerations and fair selection of the study participants (Cassell, 2000). These are basic principles, 
and they are recognised as universal as they apply all over the world. These principles will be discussed 
further in section 1.3. 
 
Other important guidelines in the history of ethics include the International ethical guidelines for 
health-related research involving human subjects developed by the Council for International 
Organizations of Medical Sciences (CIOMS) in collaboration with World Health Organisation (WHO) 
(CIOMS & WHO, 2016) and the Nuffield guidelines (Levine, 1996). These guidelines are considered 
a progression, with each succeeding document superseding its predecessors (Levine, 1996).  
 
It has been argued that the CIOMS guidelines were more successful than their predecessors in reaching 
global applicability (Levine, 1996). In addition, the author argues that the CIOMS guidelines, unlike 
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the Nuremberg Code and Helsinki Declaration, recognised certain behaviours that were ethically 
acceptable in one cultural context which may be unacceptable in another (Levine, 1996). Furthermore, 
in comparison to other guidelines, CIOMS outlined specific conditions related to the avoidance of 
exploitation particularly in underprivileged communities; for example, research should not be 
undertaken except when the research is responsive to the health requirements of the people, and it should 
be well conducted (Levine, 1996). The CIOMS guidelines also highlighted another important issue 
about the responsibility of sponsors post-trial; that is, whenever an effective product is identified as a 
result of a study, it should be made available to that particular community where the research took place 
(CIOMS & WHO, 2016). 
 
Another board governing research was established in the United Kingdom. This is known as the 
Nuffield Council on Bioethics which was established in the early 1990s as a response to the rising 
concerns regarding genetics research (Shapiro, 1995). The Nuffield Council on Bioethics raised 
important issues related to the use of human tissues and genetics. This guideline was published in 
response to public concern regarding securing informed consent to export genetic samples for research 
(O’Neil, 2003; Shapiro, 1995). It further mentioned that when externally sponsored research is proposed 
and falls outside the national priorities, its relevance must be justified to the appropriate research ethics 
committees (RECs) (McMillan & Conlon, 2004). The major role of these committees is to safeguard 
the interest of participants involved in research. The guidelines therefore emphasise that committees 
must consider relevance of the proposal to priorities in healthcare within the country, scientific validity 
and ethical acceptability of the proposed research (McMillan & Conlon, 2004). 
 
1.3 Fundamental ethical principles 
The three widely accepted philosophical principles governing research are 1) respect for autonomy, 
which puts emphasis on the rights of an individual, 2) respecting an individual and 3) protecting those 
who are incapable and vulnerable such as children and incapacitated persons (Beauchamp, 2003; 
Cassell, 2000). The principles of non-maleficence and beneficence are closely related. These principles 
require that potential research participants should not be harmed, and that benefits to participants or 
society are maximised. It is therefore important to ensure that all efforts are made to mitigate risks. The 
principle of justice entails that those who bear the burdens of research should receive the benefits 
(Cassell, 2000; Beauchamp, 2003). These principles require informed consent, risk-benefit 
determinations, and fair subject selection (Beauchamp, 2003), respectively.  
 
Most of the IRBs rely on these principles for their decision-making (Nolen & van der Putten, 2007; 
Wassenaar & Mamotte, 2012). However, due to the growing realisation that the above-mentioned 
principles may not be universally applicable across the world, there was a need to identify appropriate 
principles in relation to the context, history, culture, politics, gender, and social and economic status of 
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participants (Molyneux & Geissler, 2008). Recent works by Emanuel and colleagues have attempted to 
spell out the ethical obligations in a simplified way (Emanuel et al., 2008; Wassenaar & Mamotte, 
2012).  
 
1.4 The role of ethics review boards 
IRBs are charged with providing an independent assessment that the proposed research is ethically 
acceptable, scrutinising clinical investigators’ potential biases, and assessing compliance with 
guidelines and regulations intended to safeguard human participants (Grady, 2015). IRBs have a 
significant role to play in ensuring the ethical standards and scientific value of studies involving human 
participants. According to Gelling (1999) and WHO (2009), IRBs must ensure that the rights of research 
participants are protected. This is partly accomplished by ensuring participants receive appropriate 
information about the research. The information must be well packaged to promote understanding. 
Likewise, there should be good mechanisms in place to protect participants from any potential adverse 
consequences of the research (Gelling, 1999; WHO, 2009).  
 
In addition, IRBs have an obligation to provide guidance and ensure compliance in terms of the ethical 
conduct of research. IRBs are also obligated to the investigator, by making sure that the submitted 
protocol is treated with confidentiality, respect and due consideration. Likewise, all investigators must 
support the contribution made by IRBs to ensure that research meets the high ethical and scientific 
standards expected by the community (Gelling, 1999; WHO, 2009). Review by IRBs is required by 
international ethical standards governing research involving human participants, as well as by local 
laws, in many jurisdictions (WHO, 2009). The advantage of IRBs that operate within research 
institutions, universities and hospitals is that they are familiar with the local environments and can be 
involved in closer monitoring of ongoing research (WHO, 2009). 
 
It is within this context that IRBs are positioned to assist research investigators to comply with all forms 
of ethical standards, while generating new knowledge which can be implemented for the benefit of the 
targeted community and without compromising the welfare and dignity of the potential participants 
involved in the research. 
 
In Tanzania, the responsibility to promote research integrity falls within the mandate of the Commission 
of Science and Technology (COSTECH) (Diyamett, Szogs & Makundi, 2010); however, currently there 
is an ongoing effort to develop a National Framework for Research Integrity. In the absence of a national 
framework to guide the conduct of research in Tanzania, IRBs, where they exist, have been serving that 
purpose (Tanzania Commission for Science and Technology, 2015). With regard to health research, in 
the mid-1970s, this was managed under the umbrella of the East Africa High Commission, through the 
East African Medical Research Council (Magesa, Mwape & Mboera, 2011). However, after the collapse 
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of the East African Community, the National Institute for Medical Research (NIMR) was established 
by an Act of Parliament (No. 23 of 1979) (Magesa, Mwape & Mboera, 2011; United Republic of 
Tanzania, 1979).  
 
According to Ikingura, Kruger and Zeleke (2007, p. 154), the “national research ethics committee in 
Tanzania was established in 2002” to function “under the auspices of the Medical Research 
Coordinating Committee (MRCC)” which is “an overall coordinating body for health research in 
Tanzania”. The MRCC established the National Health Research Ethics Committee (NatHREC) to 
oversee ethics review, and approve and monitor health research in the country (Ikingura et al., 2007). 
This committee is hosted by and functions under the NIMR.  
 
Like many others countries, the NIMR standard operating procedures follow the international 
guidelines such as the Nuremberg Code, Declaration of Helsinki, CIOMS and WHO’s International 
ethical guidelines for health-related research involving human subjects, WHO and ICH (International 
Council on Harmonisation) Guidelines for good clinical practice which outline the ethical and 
scientific standards for biomedical research (National Institute for Medical Research (NIMR), 2007). 
The NIMR guidance states that compliance with the above-mentioned guidelines helps to ensure that 
the dignity, rights, safety, and well-being of research participants are promoted, and that the results of 
the research are trustworthy (NIMR, 2007).  
 
1.4.1 Composition of IRB members 
Generally, an IRB is composed of scientist and non-scientist individuals who convene to review and 
approve or reject proposals for research studies that involve human participants (Schwenzer, 2008). 
Members of these IRBs have diverse backgrounds, including for example, bioethics, clinical trials, 
biomedical science, paediatrics, epidemiology, entomology, public health, religion, law, social science 
and biostatistics (Ifakara Health Institute (IHI), 2010). These individuals are either from within or 
outside the institution hosting the IRB. The community representatives also play multiple roles in terms 
of representing the interests and concerns of the community. IRBs have an important role in protecting 
human research participants from possible harm and exploitation that may result during the conduct of 
research (Frankel & Siang, 1999; Schwenzer, 2008; Seidman, 2013).  
 
 
1.4.2 Independence of IRBs 
Any system of ethics review has to prevent undesirable research practices and promote good ethical 
research that protects participants (Bridges et al., 2011; Hesse-Biber & Leavy, 2010; Shamoo & Resnik, 
2009). IRBs should be independent in such a way that they protect research participants by ensuring 
that ethical principles are followed by researchers so as to safeguard the welfare of the participants and 
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at the same time contribute to the body of knowledge through rigorous research (Grady, 2015; Millum, 
Wendler & Emanuel, 2013; Schwenzer, 2008). Apart from reviewing and approving protocols, IRBs 
are also responsible for monitoring the already approved research involving human participants 
(Schwenzer, 2008).  
 
1.4.3 Decision-making of IRBs 
Although there are no ideal models of the deliberative process of the IRBs in the literature, more general 
theories of group decision-making processes can provide a framework which IRB can adapt for decision 
making (Candilis, 2006). Most of the IRBs incorporated the ethical issues as per international and local 
guidelines to make deliberations. For example, according to WHO guidelines, the process by which 
decision making is reached is reported as an important outcome (WHO, 2009). The decision must be 
transparent and inclusive taking into account the views of all members with different backgrounds. 
Most IRBs makes decisions through a process of consensus, whereby instead of taking a vote and 
following the decision of the majority, members attempt to make decisions that most members would 
feel comfortable with (WHO, 2009). In Tanzania, most IRBs use this approach in reviewing research 
proposals. After the review, the committee’s decision is communicated to the principal investigator. 
The decision may be categorised as: presented, if the proposal is scientifically and ethically sound 
whereby approval certificate is issued; minor revision, whereby the proposal is missing some minor but 
important issues that need to be attended to; major revision, whereby the proposal is not scientifically 
or ethical sound; not recommended, the proposal is not scientifically or ethical sound; and outright 
rejection whereby the protocol lacks scientifically and ethical sound (NIMR, 2014). The decision-
making processes are documented in the local guidelines (NIMR, 2014; ZAMREC, 2012).  
 
1.5 Challenges with ethics review identified in the literature 
Turnaround time refers to the total time taken between the submission of a protocol to the IRB 
secretariat for review until the full approval is provided to the investigator. There have been reported 
delays in reviewing protocols submitted for approval, both in developed and developing countries 
(Millum & Menikoff, 2010; Page & Nyeboer, 2017). The body of literature has documented an 
increasing bureaucratic delay associated with ethics review (Angel et al., 2008; Clarke 2014; Cleaton-
Jones, 2010; Jamrozik, 2004; Schwenzer, 2008; Wald, 2004; Warlow, 2004). For example, A study 
conducted in the United States Department of Veterans Affairs by Petersen et al. (2012) found that the 
median time for IRB approval at 43 sites in the US was 286 days, with a minimum of 52 days and a 
maximum of 798 days (Greene & Geiger, 2006; Petersen et al. 2012).  
 
These slow turnaround times have impacted on commencement of research activities (Gold & Dewa, 
2005). For example, a study conducted by Mamotte and Wassenaar (2009) revealed the experience of 
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South African social scientists by pointing out the undesirable “pragmatic reasons such as slow 
turnaround time, inadequate review and problems associated with the centralisation of ethics review” 
(p. 70). The slow turnaround time of IRBs affects researchers’ satisfaction with the ethics review 
process and their ethics compliance (Ashcraft & Krause, 2007; Liddle & Brazelton, 1996). Time delays 
may also impact on both the timeline and budget of the research – and negatively affect researcher-
funder relationships. Time delays can also weaken investigator interest in researching a rapidly 
emerging problem (Nolen & vander Putten, 2007; Silberman & Kahn, 2011).  
 
Researchers in the US and elsewhere believe that IRBs hinder their research, citing difficulties in 
seeking approval to implement their protocols (Silberman & Kahn, 2011). Reports from various sources 
have also highlighted a number of constraints and enablers related to IRBs during review. These may 
include issues such as being a slow, cumbersome and inconsistent process (Straight, 2009), excessively 
delaying research (Marsh, McMaster, Parvizi, Katz & Spindler, 2008), demotivating investigators 
(Infectious Diseases Society of America, 2009), and lack of capacity to review protocols (Emanuel, 
Wendler, Killen & Grady, 2004; Silberman & Kahn, 2011). For example, Silberman and Kahn (2011) 
documented long delays in the approval process, which nevertheless varied from one IRB to another.  
 
According to Grady (2015, p. 1), “some researchers are complaining that IRB review is time-consuming 
and burdensome without clear evidence of effectiveness at protecting human participants”. 
Additionally, “IRBs operate inconsistently and inefficiently, and focus their attention on paperwork and 
bureaucratic compliance” (Grady, 2015, p. 6). Mamotte and Wassenaar (2009) recommended further 
research to verify and explore the element of turnaround time so as to distinguish between pre-review 
delays, post-review and pre-approval delays.  
 
There are numerous plausible explanations regarding why there is divergence in turnaround times of 
ethics review (Clarke, 2014). According to Gold and Dewa (2005) the process of ethics review at several 
sites can be an overwhelming task, time-consuming, and costly (e.g. money for printing documents). In 
Tanzania, for example, if an investigator works with an external collaborator, the protocol must be 
submitted to the local investigator’s institution prior to the submission to the national IRB. In addition, 
the effectiveness of IRBs has been undermined because of the IRB system’s failure to adapt to the 
changing research environment (Christian et al., 2002). The current practice for research ethics review, 
which involves seeking ethics approval from each institution’s IRB, is not very conducive to 
collaborative, multicounty research due to the delays as a result of the need for a protocol to be reviewed 
in different countries (Gold & Dewa, 2005). Hence, there is a need to understand the nature of these 
constraints and enablers arising from reviewing protocols in order to address the problems encountered 
(Barchi, Kasimatis Singleton & Merz, 2014; Kuyare et al., 2014).  
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Among the challenges highlighted by Silaigwana and Wassenaar (2015), in their review of literature 
from 23 empirical studies, was the inadequate capacity to review and monitor studies, which hinders 
the effective functioning of IRBs. Dada and Moorad (2001) also pointed out that long turnaround times 
could be attributed to the high workload of IRBs and that most members who serve on committees work 
on a part-time voluntary basis. In addition, the use of excessive paper and bureaucracy has been reported 
as a barrier to the review process (Grady, 2010). Changes from the current paper-based ethics review 
system are necessary not only to facilitate the conduct of multi-site research but also to preserve the 
integrity of the ethics approval process in general. For example, the use of technology as a means of 
handling multisite ethics review has already been proposed (Gold & Dewa, 2005), and new technology 
such as the Internet and tablet PCs can help members receive and review protocols more timeously.  
 
Delays in processing submissions due to paper-based submissions are frustrating for both researchers 
and sponsors (Oder and Pittman, 2015; Whitney et al. 2008). Due to the competitiveness of research 
environments, it is important that institutions continuously improve their administrative support 
processes in order to support investigators to effectively accomplish the requirements associated with 
their research activities (Kakande & Namirembe, 2012; Liberale & Kovach, 2017;). Efforts have been 
made by different institutions to overcome the reported challenges through introduction of technological 
advancement. For this case, the use of computerized systems has been implemented in several industries 
or institutions in order to increase efficiency and eradicate process bottlenecks that can lead to employee 
or customer dissatisfaction. For example, the Mayo Clinic increased the quality of the services offered 
by its research administration offices by implementing a new pre-award and IRB system (Oder and 
Pittman, 2015; Smith & Gronseth, 2011). In this era, it is therefore important for the institutions to 
invest in technology such as electronic tools in order to reduce the burden and increase efficiency (Glenn 
& Sampson, 2011). 
 
1.5.1 Problem statement 
The research ethical processes are not well understood and it is reported that there is no gold standard 
against which to measure (Nicholls et al. 2015; Turner, 2004). Therefore, little information is available 
on how IRB may systematically improve their turnaround time (Page & Nyeboer, 2017. In efforts to 
improve efficiency of IRB review, specifically turnaround times, electronic review processes through 
tablet PCs were implemented. However, there is little data on whether this electronic system improves 
review turnaround time, or the perspectives of REC members who use tablet PCs. Moreover, there is a 
dearth of information on constraints and enablers of turnaround times of IRBs in Tanzania. The current 
available literature contains practically no significant studies on the enablers and turnaround times of 
IRBs or the usefulness of tablet PCs in reviewing protocols. This study aimed to determine the extent 
of variability in turnaround times for protocol review among different IRBs within Tanzania, as well as 
assess the experience and challenges of submitting and reviewing protocols after introducing tablet PCs, 
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from the perspectives of IHI-IRB members and investigators. The study also aimed to identify the key 
factors that enable or constrain turnaround times of protocol review, in order to inform appropriate 
interventions.  
 
1.6 Ethical review process in Tanzania 
In Tanzania, the NIMR through the MRCC has been mandated to grant ethical approval to conduct 
research in the country (Ikingura et al., 2007; Mashalla et al., 2009). In order to improve efficiency and 
reduce delays in issuing approvals, NIMR has permitted organisations authorised to conduct health 
research to form IRBs (Ikingura et al., 2007). Their main function is to review research proposals for 
health research intended to be conducted within or by the institution. If the research team is composed 
of local researchers (Tanzania citizens only), the research is implemented as soon as possible (Mashalla 
et al., 2009). However, if it involves external researchers, it has to be submitted to NIMR for clearance 
(Mashalla et al., 2009). 
 
According to the standard operating procedures (SOP) of these local IRBs (research institutions, 
universities and hospitals), they are supposed to perform the following roles:  
• safeguard the dignity, rights, safety, and well-being of all actual or potential research 
participants;  
• defend the principles of justice, beneficence and respect for persons;  
• provide independent, competent and timely review of ethics of proposed studies;  
• be responsible for acting in the full interest of actual or potential research participants 
and concerned communities;  
• take into account the interests and needs of researchers, having due regard for the 
requirements of relevant regulatory agencies and applicable laws;  
• provide ethical oversight of approved projects; and  
• ensure that only qualified investigators are allowed to conduct proposed studies.  
Any research or proposal dealing with human participants is submitted and reviewed in these review 
boards. According to the National Health Research Ethics Committee (NatREC) guideline, there is a 
client service charter (2014), stipulating the turn-around time for ethical approval (NIMR, 2014). The 
charter has stipulated that the timeline for the whole review process and ethical clearance would take 6 
to 8 weeks from the date of receiving a complete initial/ revised submission. However, for the expedited 
submission the review process is accomplished within four weeks after receiving the complete 
applications (NIMR, 2014).   
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1.7 Conceptual framework 
In this study, we adapted the IRB review process framework developed by Liberale and Kovac, (2017) 
summarised in Table 1 below. This framework consisted of five components including suppliers, inputs, 
process, outputs and customers (SIPOC) (Liberale & Kovach, 2017). The suppliers included 
investigators and IRB secretariat from the seven institutions visited. Secondly, the input was another 
component which included research protocols, checklist, guidelines, tablet PC and platform for the 
submission of protocols. Thirdly, the review process included: receiving of proposal by different IRBs, 
assigning of proposal to reviewers, reviewing proposals, analysing proposals in the meeting, decision 
making and sharing comments with the investigators. Fourthly, once the decision is made, it may be 
categorised into 4, approved as presented, minor revisions, major revision or outright rejection.  Finally, 
the framework composed of customers which are the investigators, research participants and the IRB 
secretariat.  Using the review process framework developed by Liberale and Kovac, (2017), this study 
determined the extent of variability in turnaround times for ethics review of proposals among different 
IRBs and highlighted the key factors that can enabled or contained the turnaround time. The study also 
assessed the reported challenges and experience of using tablet PC (input) in reviewing protocols. 
 
  
 12 
Table 1: The IRB review process framework developed by Liberale and Kovac (2017) 
 
Suppliers Input Process Outputs Customers 
IRB 
secretariats 
Protocols 1.Receive research 
protocols 
1. Approved as 
presented 
Investigators 
          IRB 1 Checklists 2.Assign to IRB 
Committee 
2. Approved 
with minor 
revision 
Research 
participants  
          IRB 2  Guidelines 3.Assign to reviewers 3. Approved 
with major 
revision or  
and the IRB 
secretariats 
          IRB 3 IRB 
systems 
4.Review research 
protocol 
4. Outright 
rejection 
 
          IRB 4 Tablet PC 5.Analyse research 
protocol in the IRB 
meeting 
  
          IRB 5  6.Decision making   
          IRB 6  7.Send decision to 
investigator 
  
          IRB 7  8.Modify protocol if need 
arise 
  
Investigators  9.Repeat steps 4-8 if need 
arise 
  
 
1.8 Objectives and research questions 
This study was guided by an overall aim, specific aims and research questions.  
 
1.8.1 Aims 
The overall aim of this study was: 
1. To identify key factors that enable or constrain turnaround times for the ethics review of 
protocols in Tanzania. 
 
Specific aims:  
1.  To determine the extent of variability in turnaround times for ethics review of protocols 
among different IRBs within Tanzania.  
 
2. To assess reported challenges and experiences of Ifakara Health Institute IRB members 
and investigators regarding submitting and reviewing protocols after the introduction of 
tablet PCs. 
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1.8.2 Research questions  
This study was guided by the following research questions: 
1. What are the key factors that enable or constrain turnaround times for reviewing 
protocols in different local IRBs in Tanzania?  
2. What is the variability in turnaround times for reviewing protocols among different IRBs 
in Tanzania? 
3. What are the challenges and experiences of reviewing protocols at Ifakara Health 
Institute IRB after the introduction of tablet PCs? 
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CHAPTER 2 
METHODOLOGY 
 
This chapter explains the general methodology used to address the research questions. It will start with 
study location, research methods, sample size and data collection processes and conclude with sections 
on rigour and ethical considerations.  
 
2.1 Location of the study  
This study was conducted in mainland Tanzania and Zanzibar. Zanzibar is a semi-autonomous region 
within the United Republic of Tanzania. However, due to financial limitations, the focus of the study 
was limited to IRBs located in Dar es Salaam, Kilimanjaro, Mwanza, Mbeya and Zanzibar. These are 
the major cities where most of the IRBs are located. Likewise, Ifakara Health Institute (IHI), Muhimbili 
University of Health and Allied sciences (MUHAS) and NIMR, which are the major IRBs, are all 
located in Dar es Salaam. The selection of the study sites and IRBs was done purposively to reflect a 
diversity of institutions (universities, research institutions, hospital-based institutions) and determined 
by willingness to participate. 
 
2.1.1 Brief description of study areas 
Dar es Salaam is the former capital and largest city in Tanzania. It is one of the largest cities in East 
Africa by population, as well as a regionally important business centre. Dar es Salaam is one of 
Tanzania’s 31 administrative regions, and consists of five districts namely: Kinondoni in the north east, 
Ilala in the centre, Ubungo in the north, Temeke in the south and Kigamboni in the south-east. 
Specifically, this study was conducted in Ilala and Kinondoni districts where most of these IRBs and 
research institutions are located. The region had a population of 4,364,541 as of the official 2012 census 
(United Republic of Tanzania, 2013).  
 
The main public health facilities in Dar es Salaam include: Muhimbili Referral Hospital, Amana 
Regional Hospital, Mwananyamala Hospital, Mnazi Mmoja Hospital, Ocean Road Hospital and Lugalo 
Military Hospital. Likewise, the major private hospitals include: Agakhan Hospital, Rabinsia Memorial 
Hospital, Regency Medical Centre, Hindu Mandal Hospital and TMJ Medical Centre. However, it is 
the duty of the municipality to provide preventive, promotive, rehabilitative and curative health care 
services in the Dar es Salaam. According to Parsa, Nekanda, McCluskey, and Page (2011), about 70% 
of the population in Dar es Salaam lives in poor and unplanned settlements.  
 
Mbeya region is located in the south-western corner of the southern highlands of Tanzania. 
Administratively, the region is divided into ten district councils including Mbeya City, Kyela, Rungwe, 
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Mbarali, Ileje, Mbozi, Chunya, Mbeya DC, Busokelo and Momba. Busekelo and Momba are new 
district councils. Mbeya IRB is located within the Mbeya Referral Hospital in Mbeya City. This region 
is further sub-divided into 28 divisions, 214 wards, 832 villages and 181 streets. The region has 415 
health facilities including hospitals, health centres and dispensaries. Of these, 82% provide maternal, 
newborn and child health (MNCH) services. In Mbeya region, HIV prevalence at 9% is higher than the 
national average (Tanzania Demographic and Health Survey (TDHS), 2015/16). 
 
Kilimanjaro region is another of Tanzania’s 31 administrative regions. The regional capital is the 
municipality of Moshi. According to the 2012 national census, the region had a population of 1,640,087 
(United Republic of Tanzania, 2013). The region is administratively divided into seven districts: Hai, 
Moshi Rural, Same, Mwanga, Rombo, Moshi Municipality and Siha. The Kilimanjaro Christian 
Medical Centre (KCMC) IRB is located in Moshi municipality. Mawenzi is a regional hospital in 
Kilimanjaro region with a 300-bed capacity. Kilimanjaro Christian Medical Centre (KCMC) is the main 
private hospital and serves as a zonal referral hospital. This hospital has more than 450 beds. 
 
Mwanza region is also one of Tanzania’s 31 administrative regions. The regional capital is Mwanza, 
which is the second largest city in Tanzania. Administratively, the region is divided into seven districts: 
Misungwi, Sengerema, Ukerewe, Nyamagana, Magu, Kwimba and Ilemela. The Bugando IRB is 
located in Nyamagana municipality. According to the 2012 national census, the Mwanza region had a 
population of 2,772,509 (United Republic of Tanzania, 2013).  
 
Zanzibar is a semi-autonomous region of Tanzania in eastern Africa. It consists of many small islands 
and two large ones: Unguja (the main island, referred to as Zanzibar) and Pemba. The capital is Zanzibar 
City, located on the island of Unguja. According to the 2012 census, Zanzibar has a population of 
1,303,569 people (United Republic of Tanzania, 2013). Administratively, Zanzibar is divided into five 
administrative regions, three in Unguja and two in Pemba. Each region is subdivided into two districts, 
which make a total of ten districts for the islands. The lowest government administrative structure at 
the community level is Shehia. The ZAMREC IRB is located in Zanzibar, Unguja Island.  
 
The geographical health infrastructure in Zanzibar is distributed into primary, secondary and tertiary 
levels of health care services. The distribution allows good access to primary services, with 95% of the 
population living within at least five kilometres of the nearest public health facility. Health facilities at 
this level provide preventive, treatment and care services for diseases and health conditions including 
malaria, upper respiratory tract infections, injuries, and water- and food-borne diseases (Zanzibar 
Ministry of Health, 2013). The capacity for the secondary level to serve as a referral centre for primary 
level facilities is, to some extent, inadequate. The upgrading of all cottage hospitals to become district 
hospitals has been necessary and hence Mkoani and Wete District Hospitals serve as regional hospitals. 
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In addition, Chake Chake Hospital will become a referral hospital for Pemba while Mnazi Mmoja 
Hospital will be transformed into a national referral centre for Zanzibar  
 
2.2 Research methods  
This was a descriptive cross-sectional study which employed a mixed-methods approach, that is, it used 
both quantitative and qualitative methods. This method is scientifically rigorous, driven by the inductive 
theoretical drive which is the generation of new theory emerging from data (Morse & Niehaus, 2009). 
It comprises qualitative and quantitative supplementary components. A mixed-method design, if 
conducted carefully, is stronger than one that uses a single method, as it enhances the validity of the 
study by corroborating the results from another perspective (Silverman, 2013; Tashakkori & Teddlie, 
2003; Onwuegbuzie & Johnson, 2006; Morse & Niehaus, 2009).  
 
The quantitative data were obtained retrospectively from databases of the NIMR, IHI and other selected 
IRBs in Tanzania (appendix 6). This methodology was selected due to the nature of the study, which 
seeks to understand the time variability and factors that enable or constrain turnaround time for ethics 
review of protocols. Furthermore, qualitative methods were also applied in triangulation, incorporating 
the advantages of each research approach because one data source may be insufficient to address the 
issues explored (Creswell & Plano Clark, 2007). For example, in-depth interviews were conducted with 
selected investigators and members of the IHI-IRB to assess the experiences and challenges of 
submitting and reviewing protocols after the introduction of tablet PCs, from the perspectives of the 
investigators and IRB members, respectively.  
 
In-depth interviews provide much more detailed information than what is available through other data 
collection methods. Furthermore, in-depth interviews offer insight into the context and hence present a 
more comprehensive picture of what transpired (Boyce & Neale 2006). Likewise, with in-depth 
interviews, one can learn from someone with experience in a particular topic and thereby broaden 
understanding in that area (Arthur, Coe, & Hedges, 2012). For this reason, key informant interviews 
were carried out with relevant stakeholders from Muhimbili University of Health and Allied Sciences 
(MUHAS) and NIMR to explore their perspectives on how to improve ethics review processes in the 
country. Table 2 summarises the objectives and data collection methods.  
 
2.3 Sample size and data collection process 
Purposive sampling was used to select IRBs for inclusion in the study (see Table 2). Purposive sampling 
is the deliberate selection of participants due to characteristics the participant possesses (Etikan et al., 
2016). It is a non-random approach that does not need fundamental theories or a set number of 
participants. The researcher decides what needs to be known and sets out to find people who can (and 
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are willing to) provide the information by virtue of their knowledge or experience (Bernard et al,. 2002; 
Tongco, 2007; Etikan, Musa, & Alkissim, 2016). This method is useful when seeking out experienced 
individuals (Etikan et al., 2016) and involves identification and selection of individuals or groups of 
individuals who are expert and knowledgeable in terms of the phenomenon of interest (Creswell & 
Plano Clark, 2011).  
 
The PI of this study ensured that all types of IRBs, such as those belonging to universities, research 
institutions and hospitals, were included in the sample. The following IRBs were selected: NIMR, 
MUHAS, KCMC, Bugando, Mbeya Medical Research and Ethics Committee and Zanzibar Medical 
Research Committee (ZAMREC) (see Table 3). Usually, protocols that are submitted through university 
IRBs mainly comprise students’ proposals. However, there are a few proposals submitted by individual 
investigators, in the form of consultancies.  
 
In terms of the qualitative sample, seven secretaries and five deputy secretaries of the visited IRBs were 
involved as key informants. In addition, nine members of IHI-IRB were involved in this study, as well 
as ten IHI investigators. Only one of the approached IHI-IRB members refused to participate. IHI 
project leaders at the time of the study who had submitted protocols in the previous year were listed and 
the leader of every fifth application was randomly selected to participate in the study. From that list, 
those who agreed to participate were consulted for an interview. Almost all the respondents were 
English speakers, for this case English tool (appendix 1) was applied in data collection exercise.  Each 
objective is linked with an appropriate research method, targeted population, tool and number of 
respondents, as shown in Table 2. 
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Table 2: Objectives and data collection methods 
Number Objective Method Targeted population  Tool Data sources 
1 To identify key 
factors that 
enable or 
constrain 
turnaround time 
of reviewing 
protocols in 
different ethics 
review boards 
In-depth 
interviews 
with key 
informants 
IRB secretariat in Dar es 
Salaam (IHI, NIMR & 
MUHAS) Kilimanjaro 
(KCMC), Mwanza 
(Bugando), Mbeya 
(Mbeya Medical 
Research and Ethical 
Committee) and 
Zanzibar (ZAMREC) 
Appendix 
1/2: In-
depth 
interview 
guide 
7 IRB 
secretaries 
 
5 IRB deputy 
secretaries 
2 To determine 
the extent of 
variability of 
turnaround time 
of reviewing 
protocols 
among different 
IRBs within 
Tanzania 
Retrospect- 
ive data from 
the registry 
IRB secretariat in Dar es 
Salaam (IHI, NIMR & 
MUHAS) Kilimanjaro 
(KCMC), Mwanza 
(Bugando), Mbeya 
(Mbeya Medical 
Research and Ethical 
Committee) and 
Zanzibar (ZAMREC) 
Appendix 6 Review of 
databases 
from 7 IRBs  
3 To assess the 
challenges and 
experience of 
submitting and 
reviewing 
protocols after 
introducing 
tablet PCs, from 
the perspectives 
of investigators 
and IRB 
members  
In-depth 
interviews 
with 
investigators 
and IRB 
members  
Investigators (who are 
project leaders and 
submitted protocols in 
the past one year) and 
IHI-IRB members were 
chosen to participate in 
this study 
Appendix 
1/2: In-
depth 
interview 
guide  
10 
investigators 
 
9 IRB 
members 
 
2.4 Data analysis 
Quantitative data were analysed using Stata software, version 10 (StataCorp, 2007). Descriptive 
statistics were conducted to determine the extent of variability in turnaround time for ethics review of 
protocols among different IRBs within Tanzania. This study also assessed the time taken from 
submitting protocols to receiving feedback or ethics approval. The analysis used median time instead 
of mean, as there were few protocols in some IRBs. The data shared was summarised and anonymised 
in order to ensure that individual respondents cannot be identified.  
 
Qualitative data were analysed using thematic analysis. Braun and Clarke (2006, p. 79) define thematic 
analysis as “a method for identifying, analysing, and reporting patterns (themes) within data”. 
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Furthermore, these authors noted that the approach helps to shape and define the data set. Through its 
theoretical freedom, thematic analysis offers a flexible and suitable research tool which can provide a 
rich and comprehensive, yet complex, account of data (Braun & Clarke, 2006). The advantage of this 
approach is that the researcher can discover themes and concepts throughout the interviews and during 
the analysis (Rubin & Rubin, 2011; Taylor & Ussher, 2001). This approach does not need the detailed 
theoretical and technical knowledge required for quantitative data analysis and hence can offer a more 
accessible form of analysis (Braun & Clarke, 2006). The PI of this study coded and categorised the 
transcripts according to the themes informed by the study objectives, using Excel software. The Excel 
spreadsheet was used to distil the qualitative information from the respondents. 
 
2.5 Validity, reliability and rigour 
Measuring the reliability of study findings needs investigators to make judgements about the 
‘soundness’ of the research in relation to the application and appropriateness of the methods used, and 
the integrity of the final conclusions (Noble & Smith, 2015). To enhance the reliability, validity and 
rigour of this study, the following strategies were applied: adoption of a mixed-methods approach; 
triangulation using more than one method during data collection approaches; and explaining to the 
participants about the purpose of the study, why it was conducted and with whom. The application of 
several research methods enables validation of data through cross-corroboration from two or more 
sources. Likewise, all interviews were audio-recorded and transcribed verbatim to allow for repeated 
revisiting of the data to check emerging themes and remain true to participants’ accounts (Noble & 
Smith, 2015).  
 
Thematic analysis was utilised to detect and identify all issues that were generated by the study 
participants (Braun & Clarke, 2006); hence, these issues formed themes which the study analysed. 
However, thematic analysis is only appropriate when the study aims to understand the current practices 
of any individual (Braun & Clarke, 2006). Likewise, the study acknowledges limitations related to 
sample size, data collection, analysis and issues related to generalisation of the findings (Sandelowski, 
1993). The reasons for this was the little funding received for data collection and limited time available 
to accomplish the dissertation.   
 
2.6 Ethical considerations  
2.6.1 Ethics review  
This study was reviewed and approved by the Ethics Review Boards of Ifakara Health Institute (IHI), 
located in Dar es Salaam (IHI/IRB/No: 002 – 2017), University of KwaZulu-Natal in South Africa 
(BREC Ref. No. BE089/17), and the National Institute of Medical Research in Tanzania (NIMR) 
(NIMR/HQ/R.8a/Vol. IX/2534). Anonymity of all study participants was ensured by removing all 
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identifying information from analysis and reports. This study was undertaken by an experienced 
researcher who ensured adequate information about the study was available to research participants. 
Individual written informed consent was obtained prior to the interview from all participants who 
participated in this study; it was drawn up in the Swahili language. The informed consent form 
(Appendix 3) explained the aim and reasons for the study, any potential risks and benefits, and the 
anticipated time taken to complete the interview. Participants were given a chance to ask questions 
during the informed consent process, and they were also informed that they could withdraw from the 
study at any time without penalty. The study complied with the CIOMS/WHO International ethical 
guidelines for health-related research involving humans (Ryan et al., 1979; Steinke, 2004).  
 
The results obtained from this study provide evidence that may usefully improve ethics review 
processes in the country. It is noteworthy to mention that the methodology applied realised the scientific 
objectives while guaranteeing research participants’ confidentiality (Emanuel et al., 2004).  
 
2.6.2 Participants’ rights  
The rights of participants were assured in terms of confidentiality and weighing the relative risks and 
benefits. 
 
Confidentiality 
Measures were taken to ensure the privacy, respect and dignity of all participants. Identities of 
participants were protected by ensuring that all data were anonymised. Confidentiality was also 
emphasised at the beginning of the interview, and a statement agreeing to maintain confidentiality was 
included as part of the participant consent forms. The researcher was also requested by the IRB to sign 
a non-disclosure agreement to maintain the confidentiality of participants’ information.  
 
Risks and benefits 
We expected no risks to participants as a result of participation. The qualitative study took place at a 
convenient place for participants. The PI minimised intrusiveness by assuring participants that they did 
not have to take part in any aspect of the research that made them feel uncomfortable (or they were 
informed that they could refuse to answer questions). 
 
The PI informed the participants that there were no direct benefits to participants from taking part in 
this research study. However, participants were informed that participation in interviews could provide 
benefits in terms of increased self-awareness, knowledge, understanding and decision-making capacity. 
Participants were not compensated nor did they incur any costs for participating in this study.  
 
 21 
CHAPTER 3 
RESULTS 
 
This chapter describes the results from data collected in the cross-sectional survey of Tanzanian IRBs 
between March and May 2018. The first objective was to determine the extent of variability in 
turnaround time of reviewing protocols among the different IRBs. In addition, the chapter will also 
present results on the key factors that enable or constrain turnaround time of reviewing protocols at 
different IRBs. Lastly, the chapter will present the results on challenges and experiences of submitting 
and reviewing protocols at IHI after introducing tablet PCs. The data presented for this objective was 
from analysis of qualitative data from the perspectives of IRB members and investigators. Data were 
collected from the databases of Bugando, IHI, KCMC, MUHAS, ZAMREC, NIMR, and Mbeya IRBs. 
The timeframe for data collection was between April 2017 and April 2018. 
 
3.1 Turnaround time 
Data were reviewed from seven IRBs (as shown in Table 3). The study reviewed minutes and records 
for the protocols submitted between April 2017 and April 2018. Since data obtained from the records 
were limited for most of the IRBs, the results are reported using median time instead of mean days. The 
average turnaround time for each institution was as follows: IRB 1- 42 median days, IRB 2 - 27 median 
days, IRB 3 - 63 median days, IRB 4 - 90 median days, IRB 5 - 15 median days, IRB 6 - 21 median 
days and IRB 7 - 28 median days. IRB 5 and IRB 6 were the best performers in terms of the turnaround 
time. The median time for review across all IRBs was 32 days, with a range of 1 to 396 days (Table 3). 
The minimum number of days taken across all IRBs was 1 (that means protocols were reviewed on the 
day submitted), and the maximum was 396 days. In the researcher’s observation, turnaround time 
tended to be shorter in IRBs with good records (such as date of submission, date comments sent or 
received and date when approval was received), as compared to the IRBs where records were poor. 
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Table 3: Turnaround time for reviewing protocols in the past year in Tanzania (April 2017 to 
April 2018) 
IRB 
name 
Number of 
protocols 
Mean 
(days) 
Minimum 
(days) 
Maximum 
(days) 
Median 
(days) 
Standard 
deviation 
IRB 1 48 48 1 147 42 33 
IRB 2  80 27.6 12 152 26.5 18 
IRB 3 10 63 17 101 63 29 
IRB 4 44 114 10 396 90 84 
IRB 5 11 55 6 235 15 70 
IRB 6 30 26 1 97 21 22 
IRB 7 20 44 1 153 28 40 
Total 243 51 1 396 32 54 
 
3.2 Key factors that enable or constrain turnaround time of reviewing protocols 
Qualitative results suggested that seven thematic issues emerged after the interviews with IRB members 
and the secretariat in the visited study areas. The themes included the following: 1) procedures for 
receiving and distribution of protocols; 2) number of reviewers assigned to protocols; 3) duration of 
reviewing protocols; 4) decision-making process; 5) reasons for delayed feedback; 6) policies and 
guidelines; and 7) training of REC members. These will be presented in the following sections.  
 
3.2.1 Procedures for receiving and distributing protocols 
This study explored the procedures for receiving, distributing and reviewing protocols. With regard to 
the procedures, most IRB secretaries acknowledged that protocols are received and checked based on 
the checklist and the guidelines. Protocols are received in hard copies as well as soft copies. Protocols 
led by local PIs are reviewed and approved if they meet requirements, but proposals with external 
collaborators are reviewed and then channelled to NIMR for national approval (Appendices 4 and 5). 
Generally, the processes for submitting protocols to IRBs are similar, as described in the quotes below: 
 
“Based on the checklist, we receive, we check as per checklist; we compile and send protocols 
to the reviewers.” (Secretariat,  Participant 1 [P1]) 
 
“Four hard copies are submitted. They are registered at registry. In the unit, department of 
health ethics, protocols are checked based on the checklist. They are given number at the 
registry. They are stamped at the finance department as confirmation that the fee has been paid.” 
(Secretariat, P3) 
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“Protocols are received from the PI, checked against the checklist and see if fee has been paid. 
If the protocol is incomplete, it is returned to the PI for completion.” (Secretariat, P6) 
 
“The secretariat receives the protocols and distributes to members; we receive both soft and 
hard copies. One IRB members is in Pemba Island. There is a requirement of receiving hard 
and soft copies. The meeting is held on the last Tuesday of the month but there is expedited 
review as well.” (Secretariat, P4) 
 
“Students’ proposals are received from Director of Postgraduate Studies, while research 
proposals from investigators are received direct in this office of research and publication. 
Proposals from Director of Postgraduate Studies (DPS) are expedited review and proposals 
from investigators are categorised into two: local PI and external PI.” (Secretariat, P5) 
 
3.2.2 Number of reviewers assigned to protocols 
If protocol submission met checklist requirements, they were assigned to specific reviewers. Protocols 
were submitted to at least two or three reviewers. However, at IHI, ZAMREC and Mbeya IRBs, 
protocols were always submitted to all members of the committee. The circulation of the submitted 
protocols to the reviewers differed from one institution to the other. At NIMR, MUHAS and KCMC, a 
respondent reported: “It takes one to three days before the proposal is assigned to the reviewer” 
(Secretariat, KCMC (P6)), while IHI, Bugando, ZAMREC and Mbeya IRBs take a week. Thereafter, 
reviewers were invited to attend a monthly meeting to finalise the review process. At IHI and ZAMREC, 
for example, protocols are reviewed every Friday and Tuesday of the end of the month, respectively. In 
the visited IRBs, the number of members ranged from 8 to 16. 
 
3.2.3 Duration of reviewing protocols 
As it was explained earlier, protocols are submitted to the secretariat of the institutions under study. 
After the protocols are circulated to the reviewers, reviewers take an average of one to two weeks. 
Protocols are sent to reviewers to consider ethical and technical aspects of the research. However, some 
review boards reportedly took up to two months to review protocols.  
 
“Usually protocols are circulated at least a week before the meeting, and all reviewers are asked 
prior to receiving of protocols if they will be available for the meeting or if they can submit 
their comments through the internet. So, there are no delays encountered, because all comments 
are given at the meeting with all members present.” (Secretariat, P8) 
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“Usually it takes three weeks to return feedback. However, if the feedback is delayed, the 
protocols are returned and assigned to another reviewer. Proposals are sent to three reviewers 
to look at ethical issue and technical aspects.” (Secretariat, P3) 
 
“Usually the feedback from reviewers is between two weeks to two months.” (Secretariat, P1) 
 
“It doesn’t take long time. On average, it takes a week to receive feedback.” (Secretariat, P7) 
 
3.2.4 Decision-making processes 
According to the IHI-IRB standard operating procedures, only members who participated in the review 
process and deliberations take part in the decision-making process. Members can only make decisions 
if the quorum requirements as stipulated in the relevant (SOPs) are satisfied. Any member with a 
conflict of interest regarding a particular proposal must not take part in the review of the proposal and 
subsequent decision-making process. Members with conflicts of interest must declare these and wait 
outside the conference or meeting room. Non-members such as project PIs and independent experts 
may be consulted as part of the review process. A decision should only be taken after there has been 
sufficient time to allow for review and discussion of an application in the absence of non-members from 
the meeting.  
 
Almost all IRB secretariats reported that the decisions are taken by consensus or, when there is voting, 
then the position voted for by the majority becomes the IRB decision. In case there is a tie, other 
members who were absent are consulted or independent expert opinion is sought.  
 
During the meetings, decisions regarding applications are categorised into the following:  
• Approval 
• Provisional approval in case of expedited review 
• Conditional approval for proposals with minor changes required which can be verified by 
secretariat without submitting to full IRB meeting 
• Major changes necessitating resubmission of the application to full IRB meeting or to appointed 
members of the IRB 
• Deferment, pending a decision at a later date 
• Disapproval.  
 
For any decision made by the IRB, clear reasons and justifications are provided and documented in 
the minutes and in the communication to the applicant. This was similar across all IRB because 
during their formation, they adapted national guidelines to fit into their setting. If a proposal requires 
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expertise that the IRB does not have, the IRB secretary, in consultation with the chairperson, may 
engage independent experts to review and give their views.  
 
“We set meetings and we sit to discuss the protocols and make decision: approved; approved 
with conditions or resubmission, whereas reviewers provide comments.” (Secretariat, P1) 
 
3.2.5 Reasons for delayed feedback 
There were some cases where feedback was delayed, especially when protocols were assigned to three 
reviewers and some of them did not share their feedback with the secretariat timeously. In addition, 
some members might not turn up for the meetings, and this may lead to an insufficient quorum and 
hence may lead to the postponement of the meetings. Most of the members are people with other 
responsibilities and full-time work; hence, they do have other conflicting responsibilities. Likewise, 
investigators may sometimes fail to adhere to the submission guidelines which may result in failure of 
reviewing their protocols in a timely manner. It was also reported that lack of experts to review 
complicated studies may also delay the review process of protocols. In addition, lack of compensation 
for IRB members’ time during review of protocols was also highlighted as one of the challenges.  
 
“Reviewers are busy with multiple obligations such as teaching, working in the hospital. So 
when you send a proposal to the reviewers, comments are not coming on timely manner until 
you make several follow-ups; until you notify members, maybe close to the meeting day, so 
that they can read the proposal.” (Secretariat, P6) 
 
“It depends: maximum of two to three weeks. If the reviewer didn’t turn up or provide timely 
comments, we request another reviewer who attended the meeting to check the proposal. If 
there is a major issue in the proposal, it will wait for another meeting. If it is not reviewed on 
time, we give a week and remind the reviewer. However, if is not reviewed on time then the 
protocol is assigned to someone else.” (Secretariat, P5) 
 
The following commonly raised queries were mentioned by participants. Firstly, requirements at 
institutional IRB level and the central IRB (NatREC), contributed to delays and duplication of efforts, 
and made the purpose of parallel submission redundant.  The participants reported that for time sensitive 
proposals, an investigator may not submit to the central level (NatREC) until the approval from a local 
IRB has been obtained. Likewise, other common problems associated with the review process were 
aligned to data management and dissemination plan which were either not written properly or 
sometimes not included in proposals. In addition, the issues of sample size determination and 
assumptions, data ownership, storage and data transfer, and hosting of data were among the issues 
associated with the delays. For example, an investigator noted:  
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“MTA, and DTA should not be the reasons for delaying the project approval at institutional-
IRB level whilst it is a legal document that is only recognized when completed and signed by 
NatREC.” (Investigator, P6) 
 
In addition, other issues raised by the participants related investigators’ failure to submit a Data Safety 
and Monitoring Broad (DSMB) charter; specify local representation of DSMB members for clinical 
trials; mention the amount of blood samples to be drawn; , specify the list of specific tests to be 
performed on the collected blood samples; and  specify how the samples would be stored or destroyed 
after the study. Likewise, some other important things mentioned by respondents related to the informed 
consent form (ICF). Participants said that most of the protocols did not specify or justify on how 
participant’s time would be compensated, the roles of each partner and/or contact information for the 
IRB. In addition, ICF are sometimes not comprehensive enough to include issues such as risks, benefits 
or purposes of the study: 
  
“Issues about compensation is sometimes nowhere to be seen in the protocol or in the ICF. It 
may sometimes appear in the ICF but not in the protocol. In addition, the roles of each partners 
are not well specified and also lack of approvals from other review boards. Most protocols lack 
contact of the independent person from the IRBs and other ICF are not comprehensive enough 
to include issues such as risk, benefit and the purposes of the study.” (Member, P2) 
 
Some of the members also faced challenges regarding making decisions on electronic data capture.  
There were no proper guidelines at institutional-levels and some delays were associated with finding a 
guidance on reviewing such proposals: 
 
“Investigators may propose the use of electronic data capture which make it difficult to make 
decisions about such proposals and hence may lead to the delays.” (Member, P2)  
  
It is evident from the study that investigators could somehow propel the delay by not adhering to the 
guidelines or checklist as reported below:  
“The issues raised some were in the guidelines but the Investigators do not refer; but due to 
these, common issues raised now and then it is good to include in the revised guidelines.” 
(Member, P8) 
 
“…investigators do not conform with the guidelines eg the application form; submission of 
Material Transfer Agreement; following the protocol submission format; references; objectives 
are not SMART.” (Member, P4) 
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In summary, majority of the participants reported that the most commonly raised queries when 
reviewing protocols were found in the methodology, dissemination and ICF sections. Issues in research 
questions and objectives not being Specific, Measurable, Attainable, Realistic, Time bound (SMART) 
were also reported by few participants.    
 
3.2.6 Policies and guidelines 
With regard to the policies and guidelines, respondents acknowledged that their institutions had 
guidelines. However, the most important challenge was that the guidelines are not updated in a timely 
manner. There was no plan for updating the guidelines in almost all visited IRBs. With the exception 
of Bugando and KCMC, it was reported that guidelines were outdated. 
 
“We have standard operating procedures and the last update was in 2012.” (Secretariat, P1) 
 
“There is a guideline which is applied to review protocols. However, it has not been updated 
since 2001. The second version was in 2009. It is the national guideline for health research 
ethics in Tanzania. It is in the NIMR website.” (Secretariat, P3) 
 
“Yes, we have SOP and guideline adapted from NIMR and it was updated in 2016. There was 
a budget for updating the guideline.” (Secretariat, P6) 
 
“We have a guideline but not updated since 2012.” (Secretariat, P4) 
 
“Yes, we have a guideline but don’t remember the last update was when.” (Secretariat, P5) 
 
“Yes, we have standard operating procedures. We usually update but there is no fixed time. 
Two years have passed since then but we have planned to set the time.” (Secretariat, P7) 
 
3.2.7 Training of REC members 
Most of the IRBs reported having trained their members using different approaches. However, for those 
whose new members had not been trained, it was reported that plans were underway to train them. Most 
of the members had completed online and short-term training organised by the NIMR  NatREC, 
MUHAS and IHI. In addition, other avenues for training of IRB members involved participation in 
GCP training, whenever there was a clinical trial project training its team.  
 
“Mainly online training such as www.TREE.org. We are invited by other colleagues e.g. 
MUHAS and NIMR. Last training was 2017.” (Secretariat, P1) 
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“Last time members’ training was 2008 (GCP training). However, different members have 
participated in different training, such as MUHAS and IHI, at different times.” (Secretariat, P4) 
 
“Yes, we had training to review qualitative research, but I don’t remember exactly the date. But 
in 2017, we did refresher training for the members recruited in 2016.” (Secretariat, P5) 
 
“Most of the time, we use projects to train members whenever they train GCP to their project 
personnel. Likewise, there is online training such as Collaborative Institutional Training 
Initiatives (CITI)which provide certificates.” (Secretariat, P6)  
 
3.3 Challenges and experiences of submitting and reviewing protocols after the  
introduction of tablet PCs: The perspectives of IRB members and investigators  
Four issues emerged regarding challenges and experiences of submitting and reviewing protocols after 
the introduction of tablet PCs, namely: 1) preference for electronic submission; 2) the challenges of 
using tablet PCs; 3) overcoming the barriers of using tablet PCs; and 4) suggestion for improvement of 
the review process.  
 
3.3.1 Preferences for electronic submission 
The secretariat of IHI-IRB introduced tablet PCs for the electronic review of protocols in 2015. 
Members received a one-day training on how to use the tablet PCs, including turning them on and off, 
and downloading and reviewing protocols. At the same time, investigators started to submit their 
protocols electronically in PDF format instead of hard copy. The protocols were received by the 
secretariat and were checked against the checklist (as shown in Appendices 4 and 5), prior to the 
electronic submission to the IRB members. Since the introduction of tablet PCs, there has not been any 
follow-up about the experience of electronic submission by the IHI secretariat with IRB members or 
investigators. This is the first attempt to share experiences from the perspective of IRB members and 
investigators.  
 
A majority of the IRB members and investigators reported that electronic submission was easy and 
reduced the burdens associated with paper-based submissions. In addition, with electronic submission, 
there were no courier costs involved in distributing hard copies of ethics applications and supporting 
documents. Furthermore, members could access and review the protocols from anywhere using their 
mobile tablet PCs, as long as they had access to the Internet. Investigators acknowledged that electronic 
submission was easy, quick, and relatively inexpensive compared to hard copy submission. It was also 
mentioned that electronic submission could reduce the chance of misplacing protocols, and the 
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submission of incorrect protocols. Investigators proposed designing a way to keep submission records 
post submission of protocols.  
 
The following typical statements from the in-depth interviews were recorded: 
 
“Very easy, it simplifies the review as one can work from anywhere and it is relatively cheap. 
IRBs should have a system whereby the received protocols have evidence of stamping; it 
simplifies documentation. We submit electronically and we document in paper. Investigators 
should have an electronic file. As we move ahead, all data will be electronic; to file big 
documents is real hectic.” (Investigator, P3) 
 
“Of course yes, I don’t carry protocols anymore. Electronic submission is more user friendly 
and the reviewer can quickly go through the documents to check anything; one can open a 
number of protocols at a time and can as well send protocols and receive on time; if you are on 
safari you can also access protocols (as compared to hard copy), but it is only when you come 
back you can read protocols. Likewise, there are some pages which might get lost during 
printing or binding, but for now we get full proposal without missed pages.” (Member, P4) 
 
“In the old days it was time-consuming; costly - as one had to print and photocopy 15 protocols; 
cost of binding; investigators can now submit electronically to the secretariat. With hard copy, 
the secretariat could use a car to submit protocols to the members, and if protocols are affected 
by water - this was another issue … and with electronic submission, reviewers can access 
protocols from anywhere.” (Investigator, P2) 
 
“Yes, so many improvements have occurred. Reading a lot of hard copy is difficult but reading 
through the soft copy is much easier. It is also easy to comment and reduces the burden of 
carrying protocols to the meeting room and the reviewer can read protocols from anywhere. It 
is easy to review, to comment and easy to refer back for clarification.” (Member, P5) 
 
“Yes, there has been very big improvement after introducing tablet PC. Firstly, it is easy to 
carry (portable), as compared to the time when we were carrying big files of hard copy. It is 
easy to share the comments straight to the PC; protocols can be accessed from anywhere.” 
(Member, P10) 
 
IRB members reported that, with electronic submission, documents can be accessed faster compared to 
hard copy. In addition, one can write and respond immediately or after reading the protocols. Members 
also reported that reading on screen was easy as one can increase the font size to read according to their 
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preference. Electronic submissions also ensure that protocols reach reviewers without any errors, and 
reduce the chance of losses. For example, the following typical excerpts from participants were 
reported: 
 
“The protocol is accessible; one can do the review at his/her convenient time. The documents 
are accessed faster than waiting for the hard copies to be delivered. And the inconveniences of 
having the hard copies handed to the member, while the member is not in the office to receive 
them; there could be a potential for losses. The tablet PC increases the chance of getting the 
protocol to the reviewer, conveniently, without any error. Reading through the screen is easy; 
one can increase the font size and read according to their convenient sight. Writing and sharing 
the comments is easy; one can respond immediately after or while reading the protocol 
documents.” (Member, P8) 
 
“In short, electronic submission is quick, not time-consuming, reduces chance of misplacing of 
protocols, and submission of wrong protocols. For example, there was a protocol which was 
wrongly submitted to one of the regulating authority and received wrong comments. With 
electronic submission, it is not possible to mix documents. With regards to cost implication, it 
is obvious that paper based is expensive.” (Investigator, P4) 
 
3.3.2 The challenges of using tablet PCs 
IRB members reported actual experienced and potential challenges in relation to using tablet PCs. 
Among the challenges experienced was the need to have sufficient data to receive or download large 
files. The costs of downloading the files were covered by IRB members themselves and hence an 
expense compared to hard copy reviews. Some members also complained about the small screen of the 
tablet PC and poor connectivity to the Internet. In addition, insufficient training on tablet use and the 
associated review process was reported by most of the members. For example, most members did not 
know how to submit comments to the secretariat using the tablet PCs. Potential challenges related to 
the Internet were also reported. Members raised concerns that hackers could have access to the files 
submitted electronically and proposed that platforms be secured with restricted member access. The 
following examples were given:  
 
“Biggest challenge is internet security, especially from hackers or access of private information 
to others. It requires support platform where members can log in into a secured platform. It also 
requires support software like adobe where you can overwrite and incorporate comments. There 
is a need for review friendly hardware, for example, the PCs where members can scribble.” 
(Member, P9) 
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“First of all, not all members are comfortable in using a tablet PC. When you read protocols 
and have got something to note down, you should write somewhere, but during the hard copy 
submission, you were just writing on the same paper. If you have nowhere to write, you might 
not get anywhere to write and can come to the meeting without comments. In downloading the 
files there is no problem; however, the challenge is to note down the comments.” (Member, P7) 
 
“The challenge of uploading is when you have insufficient bandwidth. If it was submission 
during the deadline, this could be hard. But it is simple to use electronic submission as 
compared to paper based. It [paper-based submission] cost a lot and easy to make a mistake 
when inserting page numbers. It is expensive and printing cost is too much; it is time-consuming 
and requires someone to print and arrange papers. More than hectic, it requires more time.” 
(Investigator, P7)  
 
Both the IRB members and the secretariat experienced similar challenges. At times when the secretariat 
wanted to share big files with members, they were forced to use Google drive (a tool to transfer large 
files). However, most members are not familiar with these technologies. IRB members and investigators 
explained: 
 
“Challenges are there in receiving big files. If I want to send big files, I usually use Google 
drive but some members cannot access these drives. The PC screen is very small; I want one 
like A4. Members usually come with their comments written on a piece of paper or diaries. We 
have members of different specialties; for example, there are lay members who cannot access 
these devices.” (Secretariat & Member, P1) 
 
“Access is fine. All IRB members had access but the problem was on downloading files from 
the Internet. However, sometimes the connection or downloading speed is slow. Also, PC 
should be fully charged because there is unreliable electricity. We had been given a tablet PC 
but we could not fully utilise the gadget. There was not enough time for training. It was user 
friendly - read and comment on the screen, but can share comments and write on a separate 
paper, [and] highlight and project.” (Member, P5) 
 
“When outside the wifi network, sometimes we use our own mobile network for tethering. 
However, big files cannot be downloaded and typing speed on the tablet is also challenging. In 
addition, I need time to type. Initially typing speed was very low. There is no problem after the 
download.” (Member, P3) 
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“Generally, tablet PC is good as compared to paper based. The main challenge is to access the 
documents. For example, downloading big files is a challenge. It takes time to download as 
there is no good connectivity to the Internet. If the Internet was fast enough, there could be no 
problem. There is no problem in reviewing protocols using tablet PC, but the problem is in 
downloading the files. I have not used tablet PC to send my comments to the secretariat, but I 
usually share my comments during the meeting.” (Investigator & Member, P2) 
 
It was evident from the above that there were differences in competency among members in using 
technology. For example, some members mentioned that it was possible to read and make 
comments on the screen, while others said it could not be done. 
 
3.3.3 Addressing barriers to review using tablet PCs 
Participants discussed developing an automated reminder to reviewers so as to avoid delays. It was also 
reported that electronic submission helps to reduce the turnaround time and hence improve the review 
process. Refresher training on how to complete the electronic application and upload the necessary 
documents was proposed as an important strategy to overcome the barriers. Furthermore, IHI-IRB 
members emphasised the importance of training and clear protocols on how to use technology, how to 
maintain confidentiality and how keep records.  
 
3.3.4 Suggestions for improvement of the review process 
During the in-depth interviews, IRB members and investigators from IHI were asked their opinion on 
how to improve the review process. Most of the respondents recommended the use of selected 
technology hardware and software that allows direct editing. Likewise, members suggested the use of 
a backup system with strong internet security features. It was suggested that this system should allow 
members to work on a portal that permits intersystem edits rather than download the protocols onto 
devices. In addition, members proposed that the IHI-IRB should be open for linkage with other user-
friendly facilities such as calendars, meeting minutes, agendas, discussion boards, and should permit 
questions and answers among members.  
 
Members also proposed the integration of indicators into the system to be linked with reporting and 
measuring the performance. Appropriate use of the gadget and timely provision of feedback to 
investigators was also highlighted. Although most of the challenges mentioned are not related to data 
access, most of the IRB members proposed to be given Internet bundles, as it takes considerable data 
to download the files. Looking into the discussion, it was obvious that the IRB secretariat should invest 
in technology and system strengthening as described in the following quotes:  
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“There are number of initiatives that have been established at IHI. Among these initiatives are 
quick email responses when submitting protocols, provision of tablet PCs to members and 
establishment of IRB portal. By centralising IRB and creating a portal, members can now 
receive the submitted protocols instantly. At IHI, investigators can receive feedback within two 
weeks. There is a need to congratulate members for the good job. From my own experience, 
there are institutions which delay the review process.” (Investigator, P2) 
 
“Perhaps some more guidance is required at the beginning for members to familiarise with 
downloading documents, saving the review notes and sending emails on the tablet. Some 
members prefer to send comments using laptops instead of tablet PCs.” (Member, P8) 
 
“What to improve is Internet stability, as most of them are not in the office, or give them 
‘bundles’ to improve internet access.” (Member, P2) 
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CHAPTER 4 
DISCUSSION 
 
4.1 Variability in turnaround time 
The aim of this study was to determine the extent of variability in turnaround times for ethics review of 
protocols among different IRBs in Tanzania. This was an important goal for this study because knowing 
the turnaround time will not only help the investigators to plan for their studies but also help the 
regulators to evaluate and improve their services. The median time for ethics review across the visited 
sites was 32 days, which is consistent with other studies (Adam, Kramer, Guillory, & Hancock, 2014; 
Caligiuri et al., 2017; Fontanesi, Magit, Ford, Nguyen, & Firestein, 2018; Silverman, Hull, and 
Sugarman, 2001). However, the maximum number of days for review ranged from 97-396 days.  
 
Explanations for this discrepancy were attributed to delays in receiving comments from the reviewers, 
delays in receiving comments from the IRB and delays in PI responses to the comments. However, it 
was difficult to get exact dates of when the feedback was sent back to the investigators after the review 
of the protocols submitted, indicating inadequate record-keeping. Most of the visited IRBs had no 
records on the date when the feedback was received from the reviewers or sent to the PI. With the 
availability of better records, it could help to provide a clearer picture as to whether delay was on the 
part of the secretariat or investigator. In another study it was argued that the variation related to the 
turnaround time may be associated with the workload of reviewing protocols among the IRBs (Maskell, 
Jones, Davies, & BTS/MRC MIST steering committee, 2003; Page & Nyeboer, 2017). This study 
suggests that the observed variability might have been attributable to differences in receiving feedback 
from the secretariat and responding to these. Tensions between investigators and IRBs have been 
reported elsewhere (Adams et al., 2014), due to the time taken to review protocols and its implication 
in initiation of research projects. Delay in receiving approval was mentioned as the main concern by 
most investigators (Adams et al., 2014; Page & Nyeboer, 2017)). 
 
Turnaround time has been proposed as among the parameters to measure the quality of an IRB’s work 
(Adams et al., 2014). However, the findings of this study do not provide conclusive reasons for the 
delays and whether they originate from the investigators or IRB. It is therefore recommended to record 
the turnaround time as a parameter of quality in measuring IRB performance as proposed elsewhere 
(Caligiuri et al., 2017; Fontanesi et al., 2018) 
 
  
 35 
4.2 Factors enabling or constraining turnaround time for protocol review 
The study also explored the key factors that enabled or constrained turnaround time of reviewing 
protocols in different IRBs. This study looked at the procedures for submission of protocols, assigning 
of protocols to the reviewers, duration it took to assign and review protocols, policies and guidelines, 
as well as training of IRB members across the visited IRBs. With regard to the procedures, most 
respondents who were the IRB secretaries acknowledged that protocols are received and checked based 
on the institution’s checklist and the guidelines adapted from the NatREC (Ikingura et al., 2007). If 
protocols were in line with the checklist, they were assigned to specific reviewers. Thereafter, reviewers 
were invited to attend the monthly meetings to finalise the review process. In this study, it is obvious 
that there were reported delay associated with the failure of investigators to adhere to the checklist or 
guidelines which is inline as with what has been reported elsewhere (Getz et al. 2011; Page & Nyeboer, 
2017).  
 
In these meetings, decisions were made by consensus. However, it was not always the case that 
members would attend the meetings. This may lead to an insufficient quorum, as documented elsewhere 
(Kass et al., 2007) and hence postponement of the meetings. Generally, looking into the procedures for 
submission of protocols to the secretariat of the IRBs showed that these were more or less the same 
across IRB institutions in Tanzania and beyond (Ikingura, 2007; Kass et al., 2007). Delays and obstacles 
to the commencement of research projects associated with IRB procedures and their lack of consistency 
and efficiency have also been reported elsewhere (Caligiuri et al., 2017; Hyman, 2012; Lidz et al., 2012; 
Lidz & Garverich, 2013; Kano et al., 2015; Klitzman, 2012; Page & Nyeboer, 2017; Silberman & Kahn, 
2011). 
 
With regard to the policies and guidelines, respondents acknowledged that their institutions had 
guidelines. In resonance with previous research findings (Kruger et al., 2014), a key challenge was that 
the guidelines are not updated timeously. There was no plan for updating the guidelines in almost all 
visited IRBs. SOPs should be updated regularly, at least every five years, as there are new developments 
in science and technology, which need to be accommodated (Fontanesi et al., 2018).  
 
With regard to training of the IRB members, most of the IRBs reported that plans were underway to 
train new members. However, this was not guaranteed, as most of the IRBs had limited resources and 
training opportunities (Caligiuri et al., 2017; Kass et al., 2007; Klitzman, 2008; Ndebele et al., 2014; 
Milford, Wassenaar & Slack, 2006; Mokgatla et al., 2018). Most of the members had attended online 
and short-term training organised by the NIMR-NatREC, MUHAS and IHI. In addition, other avenues 
for training of the IRB members included GCP and online training in their institutions. In this regard, it 
is of paramount importance for the IRB members to be properly trained, and they must be supported to 
accomplish the important responsibilities of protecting potential research participants (Caligiuri et al., 
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2017; Ikingura et al., 2007; Ndebele et al., 2014; Mokgatla et al., 2018). The secretariat in each of the 
visited IRBs should therefore ensure that IRB members benefit from regular training in order to protect 
the research participants. There are a number of online training opportunities for IRB members 
available, including Training and Resources in Research Ethics Evaluation (TRREE, n.d.), 
Collaborative Institutional Training Initiative (CITI program) and Protecting Human Research Online 
Training (PHRP). 
 
4.3 Challenges and experiences of submitting and reviewing protocols at IHI after 
introducing tablet PCs 
With regard to understanding the challenges and experiences of submitting and reviewing protocols at 
IHI after introducing tablet PCs, most of the IHI-IRB members and investigators acknowledged that 
electronic submission was easy to use and could reduce the workload of paper-based submission. 
These findings are consistent with other studies (Hunt et al., 2016; Maskell et al., 2003) that electronic 
submission reduced the amount of paper used, and associated costs, and helped to address some of the 
problems with delays facing IRBs (Hunt et al., 2016; Maskell et al., 2003; Oder and Pittman, 2015). 
Furthermore, this study underscores recommendations by other authors that shortening the turnaround 
time for protocol review would enhance the implementation of important clinical trials (Maskell et al., 
2003) and time-sensitive research, thus supporting the use of electronic submissions.  
 
Challenges related to technology (insufficient Internet bundles, poor connectivity, inadequate training 
on how to use electronic tablets) were among the most frequently reported challenges. In addition, 
concerns about the security of confidential files were also reported. Internet security challenges have 
been reported elsewhere (Frankel & Siang, 1999; Lu et al., 2005; Kotz, 2016; Sriram et al., 2009; Win, 
Susilo, & Mu, 2006). The information stored on the server can be accessed by different individuals, 
hence negatively impacting on preventing possible breaches of confidentiality. In this case, the main 
goal of protecting research participants cannot be enhanced. Win et al. (2006) mentioned that, with the 
development of wireless and handheld devices and connectivity to Internet through mobile phones, 
accessibility of information has improved, and it is important to safeguard the security of these devices 
so as to protect potential research participants. In addition, proper encryption schemes to ensure 
confidentiality were recommended (Frankel & Siang, 1999; Lu et al., 2005; Kotz, 2016; Sriram et al., 
2009; Win et al., 2006). 
 
4.4 Limitations of the study 
Precautions should be taken when generalising the results of the study as it was carried out in only seven 
IRBs in Tanzania. Likewise, during the initial plan, the researcher intended to conduct in-depth 
interviews with COSTECH staff. However, the study could not find someone from COSTECH to be 
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interviewed, as there were no responses to the invitation made by the PI of this study. Likewise, data 
on the date when the feedback was provided to the PI was only available from a few IRBs; hence, it 
was not taken into consideration during the analysis. This could provide information on whether the 
delay was aggravated by members or investigators. Further studies will need to look at delays caused 
by both investigators and IRB members, and the implications for the review process.  
 
Although this study was carried out in only a few IRBs, the findings may nevertheless be generally 
applicable to other settings of Tanzania and beyond the borders. This study identified important factors 
that enabled or constrained turnaround time of reviewing protocols in different IRBs in Tanzania. Our 
efforts to triangulate results from various data sources were intended to maximise reliability of the 
results and lessen possible bias (Krefting, 1991). Despite these potential concerns, the information 
provided will assist in planning a basis for monitoring the efficiency of IRBs in Tanzania. 
 
  
 38 
CHAPTER 5 
CONCLUSIONS AND RECOMMENDATIONS 
 
The evidence from this study has shown that there is an urgent need to address the issues related to the 
delays in approval process in order to improve the turnaround time in Tanzanian IRBs. There are four 
broad recommendations, presented below.   
 
5.1 Recommendations for investigators  
Investigators should adhere to the submission checklist and guidelines to avoid delays in the ethical 
approval process. Failure to adhere to the submission guidelines may result in delays in reviewing 
protocols in a timely manner. Adams et al. (2014) reported that the main factors causing delays were 
from the investigator’s side in responding to the comments in a timely manner. It is therefore important 
for the investigators to respond to comments from the IRB in a timely manner to avoid unnecessary 
delays which may impede the review process. Likewise, Caligiuri et al. (2017) have suggested an 
analytical framework for IRB quality improvement that considers adequacy of infrastructure, 
benchmarking and supportive technology. 
 
5.2 Recommendations for IRB secretariat 
As described in this thesis, it was noted that there were gaps related to security, and these may need to 
be resolved to augment the security of personal health information of participants (Win et al., 2006). It 
is therefore recommended to have a strong backup with a good security system that allows intersystem 
edits, and comments while keeping track. Furthermore, there should be training and clear protocols on 
how to use technology, how to maintain confidentiality and how keep an audit trail/records.  
 
It is also recommended that IRBs keep complete and accurate records and develop a clear template that 
may yield important information. This information may include the following: the submission date of 
the protocol, date reviewed, date when the comments were sent to investigators, date responses from 
investigators were received and date when approval was granted.  
 
In addition, it is recommended to have a backup system which should be open for linkage with other 
user-friendly facilities such as calendars, meeting minutes, agendas, discussion boards, and questions 
and answers among members. It is recommended to develop indicators linked to the system/portal for 
easy reporting and measuring the performance. It is further recommended that IRB members should be 
provided with data (airtime) so that they can download protocols conveniently. 
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5.3 Recommendations for capacity-building  
Appropriate training on the use of tablet PCs and timely provision of feedback to investigators was also 
noted as an important issue. Plans for updating the SOPs and guidelines should be in place for all visited 
and other IRBs, which were not visited. It is also recommended for IRBs to develop their own electronic 
submission system as this can reduce the workload of using a paper-based system, and can guarantee 
internet security. With electronic submission there are no transport costs involved to distribute the bulky 
documents, and members can access and review the protocols from anywhere in the world. Proper 
training on SOP updates and use of tablet PCs, as well as on the online system submission, will help to 
reduce the turnaround time. 
 
5.4 Recommendations for regulators or policy-makers 
In Tanzania, the task to promote research integrity falls within the mandate of the Commission of 
Science and Technology (COSTECH) (Diyamett et al., 2010); however, currently there is an ongoing 
effort to develop the National Framework for Research Integrity. In the absence of a national framework 
to guide the conduct of research in Tanzania, IRBs (where they exist) have been serving that purpose 
(Tanzania Commission for Science and Technology, 2015). It is therefore recommended that the 
Commission direct some funding that will assist in capacity-building and monitoring of the already 
approved protocols.  
 
5.5 Recommendations for future research 
In this study we could not conclude which of the two sides, IRBs or investigators, caused delays. It is 
therefore recommended to investigate the time from protocol submission to approval, taking into 
account when responses are provided. A further potential study area is to find out whether the 
complexity of protocols contributes to the delays. In addition, it may also be good to enquire about the 
reasons for failing to use the existing IRB software from the developed settings. Lastly, there is a need 
to assess ethical issues using Emanuel et al. framework in relation to the biomedical research ethics 
committee in other settings (Tsoka-Gwegweni & Wassenaar, 2014) 
 
5.6 Conclusion 
This study highlighted important issues which need to be addressed in order to improve the turnaround 
time of protocol review in Tanzania and beyond. Adhering to the submission checklists and guidelines 
is highly recommended to ensure that applications are reviewed timeously. Additionally, it is 
recommended that IRBs invest in technology and systems strengthening to facilitate timeous 
processing of ethics applications. It is also important for the IRBs to develop their own electronic 
submission system as this can reduce the workload of using a paper-based system, and can guarantee 
internet security issues. In this regard, IRBs should keep complete and accurate records and develop 
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a clear template that may yield important information.  Appropriate training on the use technology and 
timely provision of feedback to investigators may also contribute to the increasing performance of 
IRBs. Timely review is critical in ensuring that socially valuable research is implemented for the 
improvement of Tanzanian health systems and services.  
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APPENDICES 
 
Appendix 1: Tool English 
 
 
 
Understanding constraints and enablers of turnaround time for ethics review:  
The case of institutional review boards in Tanzania 
Field guide: Targeted audiences are: IRB secretariat, members, investigators and key stakeholders 
 
Section A: Objective 1 – To identify key factors that enable or constrain turnaround time of reviewing 
protocols in Tanzania  
 
1. Tell me about your role in the review process. What has worked well and what has not 
worked well? 
2. What are the main challenges in the approval process? (Probing issues related to follow-up 
protocol to the reviewers, what happens when one goes on leave (Who will follow?); is there 
any auto reminder for protocols delay to simplify follow-up? 
3. Are there plans in place to address the above-mentioned challenges? If yes, can you mention 
them? How are the mentioned plans implemented?  
4. What is your overall opinion in improving the approval process? 
 
Section B: Objective 2 – To determine the extent of variability of turnaround time of reviewing 
protocols among different IRBs within Tanzania  
 
1. Can you please let me know the procedures for receiving protocols from the investigators? 
2. What happens from when the protocol arrives until it is assigned to reviewers? How long does 
it take from the reception until it is assigned to reviewers? 
3. How long does it take for the reviewer to review the protocol? What happens in those 
instances where reviews are delayed? How are decisions made to assign the protocol to 
another reviewer?  
4. Does the committee have policies/guidelines that guide the review of protocols? How 
frequently are these guidelines updated? When was the last time they were updated?  
5. What training has been provided to REC members on the review of protocols? When was the 
last time of training? 
6. Now I would like to review some of your records from the time the protocol was received to 
when the certificate was issued (for the past five years). 
 
Section C: Objective 3 – To assess the challenges and experience of submitting and reviewing 
Protocols after introducing tablet PC from perspectives of investigators and IRB members, 
respectively (IHI-IRB only). 
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1. What are the challenges of using a tablet PC in the review process? (Probe about 
accessing/downloading the files, reading through the screen, writing and sharing the 
comments.) 
2. Have you noticed any improvement after the introduction of tablet PCs (What, if any?)? 
3. In your opinion, what should be done to improve the use of tablet PCs?  
4. Would you recommend this tool to other reviewing boards?  
5. (For investigators): What is your experience in submitting proposals electronically? 
6. What were the challenges prior to the use of electronic submission? (Probe cost, time, 
convenience)? 
7. What is your overall opinion for the IRB secretariat to improve the process (submission to 
certification)? 
 
Section for D: To describe the commonly raised queries when reviewing protocols at IHI-IRB 
 
1. What are the main issues raised when reviewing protocols? (Check the minutes, ask the 
secretariat.) 
2. Are those issues addressed in the improvement of the guidelines? 
 
Section E: What platforms/tools exist for reviewing of protocols in Tanzania? 
 
1. Do you have any tool/platform to simplify IRB activities? If yes, which one, electronic? 
Paper-based tool? (Probe: tablet PC, Rhinno software or IRB developed web based?) 
2. What are the challenges for the mentioned tools/platforms? 
3. If not, do you have plans in place to use any of the tools/platforms in the future? Do you have 
a budget line for your plans?  
 
Section F: Other stakeholders from the COSTECH, NIMR and MUHAS to air their opinion on how to 
improve ethics review process in the country. 
 
1. What is your opinion with regard to the current regulatory framework related to ethics review 
of research involving human participants? (Probe who oversees research ethics, accreditation 
of IRB, monitoring approved research, capacity building and challenges, and opportunity that 
exist within research regulatory bodies.)  
2. What are the main challenges in the approval process of research with human participants? 
3. What should be done to improve ethics review processes in the country?  
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Socio-demographic characteristics of the respondents (circle the appropriate answer) 
1. Sex 1) Male 2) Female 
2. Age________ 
3. Marital status  
Never married = 1  
Married = 2 
Divorced = 3 
Separated = 4  
Widowed = 5  
Living together = 6  
Don’t know = 99 
4. What is the highest level of education completed? 
5. Main economic activity  
Employed   
Government = 05 
Parastatal (govt.) = 06 
Parastatal (religious) = 07 
Parastatal (others) = 08 
Not employed = 09 
6. Number of years on the REC? 
 
 
THANK YOU 
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Appendix 2: Tool Swahili 
 
 
 
 
Understanding constraints and enablers of turnaround time for ethics review:  
The case of institutional review boards in Tanzania 
 
Field guide: Targeted audiences are: IRB secretariat, members, investigators and key stakeholders 
 
Section A: Objective 2 – To identify key factors that enable or constrain turnaround time of reviewing 
protocols in Tanzania  
 
1. Nieleze majukumu katika kupokea, kusambaza na kupitia maandiko? Katika utekelezaji wa 
majukumu yako, ni kitu gani ungependelea kiendelezwe na ni kipi unaona hakipaswi 
kuendelezwa? 
2. Je ni changamoto gani mnazipata wakati wa upokeaji, kupitiwa, kupokea mrejesho kutoka 
kwa reviewers na upatikanaji wa cheti (approval process). (Dadisi kuhusiana na ufuatiliaji 
wa andiko lililopelekwa kwa reviwer kwa mfano nini kinatokea mtu akienda likizo (nani 
atafuatilia?) Je kuna auto-reminder kurahisisha ufuatiliaji? 
3. Je mnayo mipango ya kutatua matatizo yaliyotajwa hapo juu? Kama ipo nitajie. Je ni kwa 
namna gani mnatekeleza mipango hiyo? 
4. Je una maoni gani kwa ujumla kuhusu kuboresha mfumo mzima wa kupokea, kupeleka kwa 
reviewers, kupata mrejesho kutoka kwa reviewers na kupatikana kwa cheti (Approval 
process?) 
 
Section B: Objective 2 – To determine the extent of variability in turnaround time of reviewing 
protocols among different IRBs within Tanzania  
 
1. Je unaweza kunielezea utaratibu wa kupokea andiko kutoka kwa watafiti? 
2. Je nini kinatokea wakati andiko linafika mpaka anapopatiwa mtu wa kui-pitia? Muda gani 
unapita mpaka ipangiwe mtu wa kuipitia? 
3. Je inachukua muda gani kupitia andiko? Je iwapo muda uliowekwa kupitia andiko umepita 
na hakuna majibu nini kinafanyika? Je ni muda gani umewekwa (maximum time) ili andiko 
liweze kupatiwa mtu mwingine? 
4. Je kamati ina sera/mwongozo gani wa kupitia andiko? Kwa mara ya mwisho miongozo hiyo 
imefanyiwa marekebisho lini? (Mwezi/Mwaka) 
5. Je ni mafunzo ya namna gani wamepatiwa wanakamati wanaongalia maandiko? Kwa mara 
ya mwisho wamepatiwa mafunzo hayo lini? 
6. Kwa sasa ningependa kuangalia rekodi zako kutoka pale unaporikodi kupokea maandiko, na 
kutoa cheti cha kuruhusu utafiti. 
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Section C: Objective 3 – To assess the challenges and experience of submitting and reviewing 
protocols after introducing Tablet PC, from the perspectives of investigators and IRB members, 
respectively (IHI-IRB only) 
 
1. Je ni changamoto gani mnazozipata kwa kutumia tablet PC kwa ajili ya kureview protocol? 
(Dadisi: kudowload, kusoma kupitia screen, kuandika maoni, na ku share mapendekezo) 
2. Je kuna maboresho yoyote uliyoyaona baada ya kuanza kutumia tablet PC? Kama ndiyo, 
kivipi? 
3. Una maoni gani ya kuboresha matumizi ya tablet PC? 
4. Je unaweza kupendekeza TP zitumike katika IRB nyingine? 
5. (Kwa watafiti) Je unaweza kutupa uzoefu wako kwa kutuma protocol kwa njia ya ki-
elecronic? 
6. Je unaweza kunielezea changamoto zilizokuwepo kabla ya kuanza kutumia mfumo huo? 
7. Je nini maoni yako ya ujumla wa kuboresha mfumo huu? (wa ki-elecronic) 
 
Section for D: To describe the commonly raised queries when reviewing protocols at IHI-IRB 
 
1. Je ni mambo (comments) gani zinazopatikana kutoka kwa reviewers mara kwa mara? 
(Angalia minutes, uliza sekretariat) 
2. Je hizo issues zinatumika/zinajibiwa katika kuimarisha miongozo? 
 
Section E: What platforms/tools exist in reviewing of protocols in Tanzania? 
 
1. Je mnayo tool/platform la kurahisisha shughuli za IRB (Dadisi kuhusu tablet PC, Rhinno 
software, Web-based, etc.) 
2. Je kuna changamoto gani kwa hizo tool/platform 
3. Kama hakuna, mna mipango yoyote kuhusu upatikanaji wa tool/platform siku zijazo?Unayo 
budget kwa ajili ya utekelezaji wa mipango hiyo? 
 
Section F: Other stakeholders from the COSTECH, NIMR and MUHAS to air their opinion on how to 
improve ethics review process in the country. 
 
1. Je ni nini mawazo yako kuhusu mfumo wa sasa unaohusiana na maadili wa kinchi kuhusu 
tafiti zinazohusiana na binadamu? 
2. Je kuna changamoto gani katika kupitia/kuruhusu tafiti zinazohusiana na binadamu? 
3. Nini kifanyike kuboresha kupitia maandiko ya kitafiti nchini? 
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Socio-demographic characteristics of the respondents (circle the appropriate answer) 
1. Sex 1) Male 2) Female 
2. Age________ 
3. Marital status  
4. Never married = 1  
Married  = 2 
Divorced = 3 
Separated = 4  
Widowed = 5  
Living together = 6  
Don’t know = 99 
5. What is the highest level of education completed? 
6. Main economic activity  
Employed  
Government = 05 
Parastatal (govt.) = 06 
Parastatal (religious) = 07 
Parastatal (others) = 08 
Not employed = 09 
 
 
THANK YOU 
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Appendix 3: Consent form  
 
 
Understanding constraints and enablers of turnaround time for ethics review:  
The case of institutional review boards in Tanzania 
CONSENT FORM 
 
Information sheet and consent to participate in research 
 
Date:________________________ 
 
Greetings  
 
My name is Mwifadhi Mrisho, an MSc student from Department of Psychology, University of 
KwaZulu-Natal, in South Africa. My mobile phone number is +255 655 766675 (while in Tanzania) 
and +277 41 985 975 (while in South Africa). My email address is mwifadhi.mrisho@gmail.com.  
 
You are being invited to consider participating in a study that seeks to understand the factors that 
enable or constrain turnaround time of reviewing protocols in Tanzania: The case of IRBs in Dar 
es Salaam, Mbeya, Mwanza, Kilimanjaro regions and Zanzibar. This study is aimed at determining 
the extent of variability in turnaround time of reviewing protocols among different IRBs within 
Tanzania, as well as identifying key factors that enable or constrain turnaround time of reviewing 
protocols, so as to find an appropriate intervention. Based on your knowledge/expertise related to the 
objective of this study, purposive sampling has been applied to select you/your IRB for inclusion in the 
study. The PI of this study will make sure that all IRB types (universities; research institutions and 
hospital-based) are represented. All consented members of the IHI-IRB will be involved in this study. 
Likewise, all secretaries of the visited IRB will also be involved as key informants in this study. The 
selected key investigators from IHI, as well as key informants from NIMR, TFDA and COSTECH or 
elsewhere, will be asked to participate in this study. This study is funded by the University of KwaZulu-
Natal in collaboration with Ifakara Health Institute.  
 
The study may inconvenience the participants in terms of time as they would be required to spend about 
an hour responding to the research questions. This study will provide no direct benefits to participants. 
However, the study is intended to improve the review process and also contribute to the process being 
environmentally friendly by using electronic devices to review protocols and hence reducing the use of 
paper.  
 
Participation in this research is voluntary and participants may withdraw participation at any point; in 
the event of refusal/withdrawal of participation, participants will not incur any penalty or loss of 
treatment or other benefit to which they are normally entitled.  
 
No costs may be incurred by prospective participants as a result of participation in the study. The 
researcher will bear all costs by meeting the prospective participants at a place of their convenience. 
There are no incentives or reimbursements for participation in the study.  
 
Information that you provide will remain confidential and will only be used in this study. The PI will 
have access to the data and, during analysis, results will be coded so that your answers and results are 
not linked to your name. Information will be kept secured by the PI. 
 
------------------------------------------------------------------------------------------------------------------ 
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CONSENT  
 
I ___________________________________ have been informed about the study entitled 
Understanding constraints and enablers of turnaround time for ethics review:  
The case of institutional review boards in Tanzania by the researcher Dr Mwifadhi Mrisho.  
 
I understand the purpose and procedures of the study Understanding of factors that enable or 
constrain turnaround time of reviewing protocols in Tanzania: The case of IRBs in Dar es Salaam, 
Mbeya, Mwanza, Kilimanjaro regions and Zanzibar and I have been given an opportunity to ask 
questions about the study and have had them answered to my satisfaction. 
 
I declare that my participation in this study is entirely voluntary and that I may withdraw at any time 
without affecting any treatment or care that I would usually be entitled to. 
 
I have been informed that there will be no compensation or medical treatment and cost associated with 
the study. The researcher will bear all the costs. 
  
If I have any further questions/concerns or queries related to the study, I understand that I may contact 
the researcher at (contact provided below) or the secretariat (contact provided below). 
 
If you have any questions or need clarification at any time before signing the consent form or during 
the study period, do not hesitate to ask me. I may be contacted through +255 655 7666 75 or 
mwifadhi.mrisho@gmail.com. This study has been ethically reviewed and approved by the Ifakara 
Health Institute Review Board (approval number_________________and University of KwaZulu-
Natal__________________________). 
 
In the event of any problems or concerns/questions, you may further contact the secretariat, Institutional 
Review Board Mr Bakari Fakih through +255 713 545 802 or you mays also write to:  
 
The secretariat, 
Institutional Review Board 
Ifakara Health Institute 
P.O. BOX 78373 
Dar es Salaam  
Tanzania 
  
 
____________________    ____________________ 
Signature of participant   Date 
 
 
____________________    _____________________ 
Signature of witness    Date 
(where applicable)    
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Appendix 4: IHI-IRB application checklist 
 
S/N  
1 Signed cover letter from investigator (should also include physical address, fax number 
telephone numbers preferred personal number and email address) 
2 Protocol contents to include summary of the study, background, objectives, rationale, 
methodology, personnel, budget, justification, if applicable a statement of compensation for 
study participation (including expenses and access to medical care) to be given to research 
participants, and agreement statement to comply with ethical principles set out in relevant 
guidelines 
3 An electronic version of research protocol 
4 Informed consent (English and Swahili) 
5 Instruments for data collection (English and Swahili, when applicable) 
6 Up to date CVs of PI and co-Investigator (if applicable) 
7 Investigator’s brochure, if it is clinical trial  
8 Importation approval by the Tanzania Food and Drug Authority (may be submitted at a later 
stage) 
9 An adequate summary of all safety, pharmacological, pharmaceutical, and toxicological data 
available on the study product, together with a summary of clinical experience with the study 
product to date (e.g., recent investigator’s brochure, published data, summary of the product’s 
characteristics). 
10 All materials to be used (including advertisements) for the recruitment of potential research 
participants must be attached to the protocol.  
11 Budget 
12 The study must be approved by IHI Thematic Group Leader 
13 A signed copy of an invoice with cost centre or receipt of payment should be attached 
Source: IHI-IRB application form 
 
 
 
 
  
 59 
Appendix 5: NIMR application checklist: (a) New proposal/amendment 
 
S/N  
1 National Health Research Ethics Committee (NatHREC) Application Form 
2 Cover letter with institution logo signed by PI or CO-PI 
3 Commitment letter from affiliated institution and/or local government officials 
4 Full study proposal(s) or amendment (s) with all relevant sections: Summary, background and 
rationale, objectives, methodology, ethical considerations, budget and budget justification, 
references and appendices, etc. 
5 Informed consent forms/assent forms in English and Kiswahili with institution logo and local 
PI and NatHREC contacts 
6 IRB approval certificate from affiliating institution(s) where applicable 
7 Data collection tools in English and Kiswahili 
8 Elaborated recruitment procedure 
9 Written information to be provided to participants in English and Kiswahili 
10 Curriculum vitae (CVs) and composition of the research team 
11 Evidence of application and registration fees payment (bank slip) 
12 Filled-in Data Transfer Agreement (DTA) and/or Material Transfer Agreement (MTA) (where 
applicable) 
 For clinical trials: Additional documents must be submitted with application 
13 Investigator’s brochure and case report forms 
14 Proof of insurance coverage arrangement 
15 List of DSMB members (with at least one Tanzanian) 
2. Renewal or extension 
1 Cover letter with institution logo signed by PI or CO-PI 
2 Progress report of study indicating what is to be covered in the renewal period 
3 Copy of previous ethical clearance certificate 
4 Evidence of payment (bank slip) 
Progress report 
1 Cover letter with institution logo signed by PI or CO-PI 
2 Progress report of study including status of:  
- Activities that have been conducted  
- Activities that remain to be conducted 
3 Copy of previous ethical clearance certificate 
Source: NIMR checklist form 
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Appendix 6: Data extraction tool 
 
 
 
 
Data extraction tool 
 
 
S/N Protocol title PI Date 
Submitted 
Date 
received 
comments 
Date 
received 
approval 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
